New Ileitis vaccine
// 30 Aug 2006
Enterisol® Ileitis is the first enteric vaccine to have received marketing authorization in the EU to improve pig’s weight gain and to reduce body weight variability.
In 2001, Enterisol® Ileitis has been launched in North America and has been licensed in three South-American countries, in two Asian countries, in Australia and nineteen European countries. Since 2001, more than 110 million pigs have been vaccinated worldwide, establishing Ileitis control as an essential part of professional pig health management.
Enterisol® Ileitis is a further element in the company’s range of innovative swine vaccines (e.g. Ingelvac® PRRS MLV) and up-to-date animal health management solutions for the farmer and the veterinarian.
Boehringer Ingelheim GmbH
Email: HARDGE@ing.boehringer-ingelheim.com
Website: http://www.boehringer-ingelheim.com:80/
Tel: +49
6132 77 82 71 / Fax: +49 6132 77 66 01
Mail a friend
Print
